BiomX Inc. (AMEX:PHGE) does about 475.22K shares in volume on a normal day but saw 437609 shares change hands in Friday trading. The company now has a market cap of 10.54M USD. Its current market price is $0.35, remained unchanged the previous close of $0.35. The 52 week high reached by this stock is $2.14 whilst the lowest price level in 52 weeks is $0.13. The script in recent trading has seen the stock touch a high of $0.39 and a low of $0.34.
BiomX Inc. (PHGE) has a 20-day trading average at $0.3540 and the current price is -83.64% off the 52-week high compared with 165.15% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.2713 and its 200-day simple moving average is $0.5137. If we look at the stock’s price movements over the week, volatility stands at 11.80%, which increases to 12.92% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 56.92 to suggest the stock is neutral.
3 analysts observing the BiomX Inc. (PHGE) stock have set the 12-month price targets for the company’s shares at between $3.00 and $10.00. The consensus objective for the share price is $5.25, suggesting that the stock has a potential upside of 93.33% over the period. The median price target is 94.17% away from the current levels at $6.00.
FactSet Research has provided data showing that 3 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 3 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on April 15, 2021 when Ladenburg Thalmann initiated the stock to “Buy” and issued a price target of $25.
The current price level is -0.14%, 30.15%, and -32.51% away from its SMA20, SMA50, and SMA200 respectively, with the PHGE price moving below the 50-day SMA on February 17. BiomX Inc. (PHGE) stock is up 5.42% over the week and 38.01% over the past month. Its price is 87.47% year-to-date and -80.77% over the past year.
Its 12-month price target is $6.00. To reach the target analysts have set, the stock logically needs to grow 93.33 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $3.00, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $10.00.
Outstanding shares total 29.91M with insiders holding 19.37% of the shares and institutional holders owning 20.70% of the company’s common stock. The company has a return on equity of -89.60%. The beta has a value of 1.40. Price to book ratio is 0.39.
According to a U.S. Securities and Exchange Commission filing, Royce Smaller Companies Growth Fu has reduced its position in BiomX Inc. (PHGE) to 158,655 shares, mirroring a recent drop by -51.73%. Royce Smaller Companies Growth Fu dumped -0.17 million shares of BiomX Inc. common stock bringing its total worth to about $59178.0 at the end of recent close, SEC documents show. Royce Smaller Companies Growth Fu isn’t the only investment manager who changed stakes and is followed by Bridgeway Ultra Small Company Mar, which sold off 9200.0 shares to end up with 49,500 shares worth $18464.0. Psagot ETF raise their holdings by 92.56% in the company over the course of the most recent quarter. It now holds a 0.01% position in BiomX Inc. thanks to 3081.0 shares amounting to $1149.0.
